FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Olli Carpén

Research Profile

Chemicals & Drugs

Anatomy

Procedures

Immunohistochemistry

Physiology

Disorders

Phenomena

Phosphorylation

Co-author Network

Publications

TOP 3
Johanna Hynninen; Maija Lavonius; Sinikka Oksa; Olli Carpén; Seija Grénman; Annika Auranen
Is perioperative visual estimation of intra-abdominal tumor spread reliable in ovarian cancer surgery after neoadjuvant chemotherapy?
Minja Laulajainen; Maria Melikova; Taru Muranen; Olli Carpén; Mikaela Grönholm
Distinct overlapping sequences at the carboxy-terminus of merlin regulate its tumour suppressor and morphogenic activity.
Johanna Hynninen; Jukka Kemppainen; Maija Lavonius; Irina Lisinen; Marko Seppänen; Johanna Virtanen; Annika Auranen; Olli Carpén; Kirsti Dean; Seija Grénman
FDG PET/CT in staging of advanced epithelial ovarian cancer: frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Olli Carpén (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Johanna Hynninen; Maija Lavonius; Sinikka Oksa; Olli Carpén; Seija Grénman; Annika Auranen
Is perioperative visual estimation of intra-abdominal tumor spread reliable in ovarian cancer surgery after neoadjuvant chemotherapy?
Gynecologic oncology 2013;128(2):229-32.
2012: Minja Laulajainen; Maria Melikova; Taru Muranen; Olli Carpén; Mikaela Grönholm
Distinct overlapping sequences at the carboxy-terminus of merlin regulate its tumour suppressor and morphogenic activity.
Journal of cellular and molecular medicine 2012;16(9):2161-75.
2012: Johanna Hynninen; Jukka Kemppainen; Maija Lavonius; Irina Lisinen; Marko Seppänen; Johanna Virtanen; Annika Auranen; Olli Carpén; Kirsti Dean; Seija Grénman
FDG PET/CT in staging of advanced epithelial ovarian cancer: frequency of supradiaphragmatic lymph node metastasis challenges the traditional pattern of disease spread.
Gynecologic oncology 2012;126(1):64-8.
2012: Mervi J Toriseva; Olli Carpén; Masaki Inada; Stephen M Krane; Matti Laato; Suvi T Ruohonen; Eriika Savontaus; Veli-Matti Kähäri
MMP-13 regulates growth of wound granulation tissue and modulates gene expression signatures involved in inflammation, proteolysis, and cell viability.
PloS one 2012;7(8):e42596.
2011: Minja Laulajainen; Taru Muranen; Tuula A Nyman; Olli Carpén; Mikaela Grönholm
Multistep phosphorylation by oncogenic kinases enhances the degradation of the NF2 tumor suppressor merlin.
Neoplasia (New York, N.Y.) 2011;13(7):643-52.
2011: Eija A Korkeila; Kari Syrjänen; Riyad Bendardaf; Minja Laulajainen; Olli Carpén; Seppo Pyrhönen; Jari Sundström
Preoperative radiotherapy modulates ezrin expression and its value as a predictive marker in patients with rectal cancer.
Human pathology 2011;42(3):384-92.
2011: Pia Boström; Olli Carpén; Peter J Roberts; Karl-Ove Söderström; Mirva Söderström; Tero Vahlberg; Pirkko Hirsimäki
MMP-1 expression has an independent prognostic value in breast cancer.
BMC cancer 2011;11():348.
2010: Maria Gardberg; Kati Talvinen; Katja Kaipio; Kristiina Iljin; Caroline Kampf; Mathias Uhlen; Olli Carpén
Characterization of Diaphanous-related formin FMNL2 in human tissues.
BMC cell biology 2010;11():55.
2009: Jutta Huvila; Annika Brandt; Clarissa Rios Rojas; Salla Pasanen; Lauri Talve; Pirkko Hirsimäki; Vidal Fey; Leena Kytömäki; Pekka Saukko; Olli Carpén; Juhani T Soini; Seija Grénman; Annika Auranen
Gene expression profiling of endometrial adenocarcinomas reveals increased apolipoprotein E expression in poorly differentiated tumors.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2009;19(7):1226-31.
2009: Tero Satomaa; Annamari Heiskanen; Iréne Leonardsson; Jonas Angström; Anne Olonen; Maria Blomqvist; Noora Salovuori; Caj Haglund; Susann Teneberg; Jari Natunen; Olli Carpén; Juhani Saarinen
Analysis of the human cancer glycome identifies a novel group of tumor-associated N-acetylglucosamine glycan antigens.
Cancer research 2009;69(14):5811-9.
2009: Outi Heikkinen; Perttu Permi; Harri Koskela; Olli Carpén; Jari Ylänne; Ilkka Kilpeläinen
Solution structure of the first immunoglobulin domain of human myotilin.
Journal of biomolecular NMR 2009;44(2):107-12.
2009: Julien Ochala; Olli Carpén; Lars Larsson
Maintenance of muscle mass, fiber size, and contractile function in mice lacking the Z-disc protein myotilin.
Upsala journal of medical sciences 2009;114(4):235-41.
2008: Adam Ibrahim Elzagheid; Eija Korkeila; Riyad Bendardaf; Abdelbaset Buhmeida; Suvi Heikkilä; Antti Vaheri; Kari Syrjänen; Seppo Pyrhönen; Olli Carpén
Intense cytoplasmic ezrin immunoreactivity predicts poor survival in colorectal cancer.
Human pathology 2008;39(12):1737-43.
2008: M Laulajainen; Taru Muranen; Olli Carpén; Mikaela Grönholm
Protein kinase A-mediated phosphorylation of the NF2 tumor suppressor protein merlin at serine 10 affects the actin cytoskeleton.
Oncogene 2008;27(23):3233-43.
2008: Duygu Selcen; Olli Carpén
The Z-disk diseases.
Advances in experimental medicine and biology 2008;642():116-30.
2007: Anja Ruppelt; Randi Mosenden; Mikaela Grönholm; Einar M Aandahl; Derek Tobin; Cathrine R Carlson; Hilde Abrahamsen; Friedrich W Herberg; Olli Carpén; Kjetil Taskén
Inhibition of T cell activation by cyclic adenosine 5'-monophosphate requires lipid raft targeting of protein kinase A type I by the A-kinase anchoring protein ezrin.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(8):5159-68.
2007: Oskari Heikinheimo; Susheel Vani; Olli Carpén; Annamaija Tapper; Päivi Härkki; Eeva-Marja Rutanen; Hilary Critchley
Intrauterine release of progesterone antagonist ZK230211 is feasible and results in novel endometrial effects: a pilot study.
Human reproduction (Oxford, England) 2007;22(9):2515-22.
2007: Taru Muranen; Mikaela Grönholm; Aurelie Lampin; Dominique Lallemand; Fang Zhao; Marco Giovannini; Olli Carpén
The tumor suppressor merlin interacts with microtubules and modulates Schwann cell microtubule cytoskeleton.
Human molecular genetics 2007;16(14):1742-51.
2007: Monica Moza; Luca Mologni; Ras Trokovic; Georgine Faulkner; Juha Partanen; Olli Carpén
Targeted deletion of the muscular dystrophy gene myotilin does not perturb muscle structure or function in mice.
Molecular and cellular biology 2007;27(1):244-52.
2007: Leif Carlsson; Ji-Guo Yu; Monica Moza; Olli Carpén; Lars-Eric Thornell
Myotilin: a prominent marker of myofibrillar remodelling.
Neuromuscular disorders : NMD 2007;17(1):61-8.
2007: Krista Nuotio; Mikko I Mäyränpää; Jani Saksi; Petra Ijas; Tiina Sairanen; Olli Carpén; Lauri Soinne; eija saimanen; Oili Salonen; Mauri Lepäntalo; Petri T Kovanen; Markku Kaste; Perttu J Lindsberg
Endothelial apoptosis does not determine symptom status in carotid artery disease.
Cerebrovascular diseases (Basel, Switzerland) 2007;23(1):27-34.
2006: Mikko Rönty; Suvi-Katri Leivonen; Boris Hinz; Andrew Rachlin; Carol A Otey; Veli-Matti Kähäri; Olli Carpén
Isoform-specific regulation of the actin-organizing protein palladin during TGF-beta1-induced myofibroblast differentiation.
The Journal of investigative dermatology 2006;126(11):2387-96.
2006: Mikaela Grönholm; Taru Muranen; Garabet G Toby; Tamara Utermark; C Oliver Hanemann; Erica A Golemis; Olli Carpén
A functional association between merlin and HEI10, a cell cycle regulator.
Oncogene 2006;25(32):4389-98.
2006: Jari Suvilehto; Merja Roivainen; Mikko Seppänen; Seppo Meri; Tapani Hovi; Olli Carpén; Anne Pitkäranta
Rhinovirus/enterovirus RNA in tonsillar tissue of children with tonsillar disease.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2006;35(3):292-7.
2005: Pernilla von Nandelstadh; Mikaela Grönholm; Monica Moza; Arja Lamberg; Harri Savilahti; Olli Carpén
Actin-organising properties of the muscular dystrophy protein myotilin.
Experimental cell research 2005;310(1):131-9.
2005: Luca Mologni; Monica Moza; Maciej Lalowski; Olli Carpén
Characterization of mouse myotilin and its promoter.
Biochemical and biophysical research communications 2005;329(3):1001-9.
2005: Mikaela Grönholm; Tambet Teesalu; Jaana Tyynelä; Katja Piltti; Tom Böhling; Kirmo Wartiovaara; Antti Vaheri; Olli Carpén
Characterization of the NF2 protein merlin and the ERM protein ezrin in human, rat, and mouse central nervous system.
Molecular and cellular neurosciences 2005;28(4):683-93.
2005: Leena Heiska; Olli Carpén
Src phosphorylates ezrin at tyrosine 477 and induces a phosphospecific association between ezrin and a kelch-repeat protein family member.
The Journal of biological chemistry 2005;280(11):10244-52.
2005: Taru Muranen; Mikaela Grönholm; G Herma Renkema; Olli Carpén
Cell cycle-dependent nucleocytoplasmic shuttling of the neurofibromatosis 2 tumour suppressor merlin.
Oncogene 2005;24(7):1150-8.
2005: Erno M P Lehtonen-Smeds; Mikko Mayranpaa; Perttu J Lindsberg; Lauri Soinne; eija saimanen; Antero A J Jarvinen; Oili Salonen; Olli Carpén; Riitta Lassila; Seppo Sarna; Markku Kaste; Petri T Kovanen
Carotid plaque mast cells associate with atherogenic serum lipids, high grade carotid stenosis and symptomatic carotid artery disease. Results from the helsinki carotid endarterectomy study.
Cerebrovascular diseases (Basel, Switzerland) 2005;19(5):291-301.
2004: Ari Rouhiainen; Juha Kuja-Panula; Erika Wilkman; Jukka S Pakkanen; Jan Stenfors; Raimo K Tuominen; Mauri Lepäntalo; Olli Carpén; Jaakko Parkkinen; Heikki Rauvala
Regulation of monocyte migration by amphoterin (HMGB1).
Blood 2004;104(4):1174-82.
2004: Heikki Rihkanen; Olli Carpén; Merja Roivainen; Antti Vaheri; Anne Pitkäranta
Rhinovirus in adenoid tissue.
International journal of pediatric otorhinolaryngology 2004;68(7):903-8.
2004: Mikko Rönty; Anu Taivainen; Monica Moza; Carol A Otey; Olli Carpén
Molecular analysis of the interaction between palladin and alpha-actinin.
FEBS letters 2004;566(1-3):30-4.
2004: Kaija Alfthan; Leena Heiska; Mikaela Grönholm; G Herma Renkema; Olli Carpén
Cyclic AMP-dependent protein kinase phosphorylates merlin at serine 518 independently of p21-activated kinase and promotes merlin-ezrin heterodimerization.
The Journal of biological chemistry 2004;279(18):18559-66.
2004: Vappu Sirén; JP Antinheimo; Juha Jääskeläinen; T Böhling; Olli Carpén; Antti Vaheri
Plasminogen activation in neurofibromatosis 2-associated and sporadic schwannomas.
Acta neurochirurgica 2004;146(2):111-8.
2003: Mikaela Grönholm; Lutz Vossebein; Cathrine R Carlson; Juha Kuja-Panula; Tambet Teesalu; Kaija Alfthan; Antti Vaheri; Heikki Rauvala; Friedrich W Herberg; Kjetil Taskén; Olli Carpén
Merlin links to the cAMP neuronal signaling pathway by anchoring the RIbeta subunit of protein kinase A.
The Journal of biological chemistry 2003;278(42):41167-72.
2003: Lea Pylkkänen; Maarit Sarlomo-Rikala; Maija Wessman; Eija Hämäläinen; Markku Sainio; Kirsti Husgafvel-Pursiainen; Olli Carpén
Chromosome 22q alterations and expression of the NF2 gene product, merlin, in gastrointestinal stromal tumors.
Human pathology 2003;34(9):872-9.
2003: Rolf Schröder; Jens Reimann; Paula Salmikangas; Christoph S Clemen; Y K Hayashi; I Nonaka; K Arahata; Olli Carpén
Beyond LGMD1A: myotilin is a component of central core lesions and nemaline rods.
Neuromuscular disorders : NMD 2003;13(6):451-5.
2003: Jarna Moilanen; Heini Lassus; Arto Leminen; Antti Vaheri; Ralf Bützow; Olli Carpén
Ezrin immunoreactivity in relation to survival in serous ovarian carcinoma patients.
Gynecologic oncology 2003;90(2):273-81.
2003: Krista Nuotio; Perttu J Lindsberg; Olli Carpén; Lauri Soinne; E M P Lehtonen-Smeds; eija saimanen; Riitta Lassila; Tiina Sairanen; Seppo Sarna; Oili Salonen; Petri T Kovanen; Markku Kaste
Adhesion molecule expression in symptomatic and asymptomatic carotid stenosis.
Neurology 2003;60(12):1890-9.
2003: Vappu Sirén; Petteri Kauhanen; Olli Carpén; Michael Luther; Mauri Lepäntalo; Antti Vaheri; Riitta Lassila
Urokinase, tissue-type plasminogen activator and plasminogen activator inhibitor-1 expression in severely stenosed and occluded vein grafts with thrombosis.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2003;14(4):369-77.
2003: Matti Autero; Leena Heiska; Lars Rönnstrand; Antti Vaheri; Carl G Gahmberg; Olli Carpén
Ezrin is a substrate for Lck in T cells.
FEBS letters 2003;535(1-3):82-6.
2003: Paula Salmikangas; Peter F.M. van der Ven; Maciej Lalowski; Anu Taivainen; Fang Zhao; Heli Suila; Rolf Schröder; Pekka Lappalainen; Dieter O Fürst; Olli Carpén
Myotilin, the limb-girdle muscular dystrophy 1A (LGMD1A) protein, cross-links actin filaments and controls sarcomere assembly.
Human molecular genetics 2003;12(2):189-203.
2003: Olli Carpén
[Myocyte sarcolemmal and cytoskeleton proteins in inherited muscular diseases].
Duodecim; lääketieteellinen aikakauskirja 2003;119(3):179-86.
2002: Anne Pitkäranta; Heikki Rihkanen; Olli Carpén; Antti Vaheri
Rhinovirus RNA in children with longstanding otitis media with effusion.
International journal of pediatric otorhinolaryngology 2002;66(3):247-50.
2002: Lea Pylkkänen; Markku Sainio; Tiina Ollikainen; Karin Mattson; Stig Nordling; Olli Carpén; Kaija Linnainmaa; Kirsti Husgafvel-Pursiainen
Concurrent LOH at multiple loci in human malignant mesothelioma with preferential loss of NF2 gene region.
Oncology reports 2002;9(5):955-9.
2002: Perttu J Lindsberg; Jyrki Launes; L Tian; H Välimaa; V Subramanian; Jukka Sirén; Laura Hokkanen; T Hyypiä; Olli Carpén; Carl G Gahmberg
Release of soluble ICAM-5, a neuronal adhesion molecule, in acute encephalitis.
Neurology 2002;58(3):446-51.
2001: O M Mykkänen; Mikaela Grönholm; Mikko Rönty; Maciej Lalowski; Paula Salmikangas; Heli Suila; Olli Carpén
Characterization of human palladin, a microfilament-associated protein.
Molecular biology of the cell 2001;12(10):3060-73.
2001: Satu Mustjoki; Riitta Alitalo; Erkki Elonen; Olli Carpén; Carl G Gahmberg; Antti Vaheri
Intercellular adhesion molecule-1 in extravasation of normal mononuclear and leukaemia cells.
British journal of haematology 2001;113(4):989-1000.
2001: Luca Mologni; Paula Salmikangas; F Fougerousse; Jacques Beckmann; Olli Carpén
Developmental expression of myotilin, a gene mutated in limb-girdle muscular dystrophy type 1A.
Mechanisms of development 2001;103(1-2):121-5.
2000: Peter F.M. van der Ven; S Wiesner; Paula Salmikangas; Stephan Keller; Mirko Himmel; Stefan Kempa; Katrin Hayess; Dirk Pacholsky; Anu Taivainen; Rolf Schröder; Olli Carpén; Dieter O Fürst
Indications for a novel muscular dystrophy pathway. gamma-filamin, the muscle-specific filamin isoform, interacts with myotilin.
The Journal of cell biology 2000;151(2):235-48.
2000: Markku Sainio; Juha Jääskeläinen; Hannele Pihlaja; Olli Carpén
Mild familial neurofibromatosis 2 associates with expression of merlin with altered COOH-terminus.
Neurology 2000;54(5):1132-8.
2000: JP Antinheimo; Risto Sankila; Olli Carpén; Eero Pukkala; Markku Sainio; Juha Jääskeläinen
Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas.
Neurology 2000;54(1):71-6.
2000: JP Antinheimo; Satu-Leena Sallinen; Pauli Sallinen; Hannu Haapasalo; Heikki Helin; Nina Horelli-Kuitunen; Maija Wessman; Markku Sainio; Juha Jääskeläinen; Olli Carpén
Genetic aberrations in sporadic and neurofibromatosis 2 (NF2)-associated schwannomas studied by comparative genomic hybridization (CGH).
Acta neurochirurgica 2000;142(10):1099-104; discussion 1104-5.
1999: Paula Salmikangas; O M Mykkänen; Mikaela Grönholm; Leena Heiska; Juha Kere; Olli Carpén
Myotilin, a novel sarcomeric protein with two Ig-like domains, is encoded by a candidate gene for limb-girdle muscular dystrophy.
Human molecular genetics 1999;8(7):1329-36.
1999: Mikaela Grönholm; Markku Sainio; Fang Zhao; Leena Heiska; Antti Vaheri; Olli Carpén
Homotypic and heterotypic interaction of the neurofibromatosis 2 tumor suppressor protein merlin and the ERM protein ezrin.
Journal of cell science 1999;112 ( Pt 6)():895-904.
1998: P Majander-Nordenswan; Markku Sainio; O Turunen; Juha Jääskeläinen; Olli Carpén; Juha Kere; Antti Vaheri
Genomic structure of the human ezrin gene.
Human genetics 1998;103(6):662-5.
1998: O Turunen; Markku Sainio; Juha Jääskeläinen; Olli Carpén; Antti Vaheri
Structure-function relationships in the ezrin family and the effect of tumor-associated point mutations in neurofibromatosis 2 protein.
Biochimica et biophysica acta 1998;1387(1-2):1-16.
1998: Leena Heiska; Kaija Alfthan; Mikaela Grönholm; P Vilja; Antti Vaheri; Olli Carpén
Association of ezrin with intercellular adhesion molecule-1 and -2 (ICAM-1 and ICAM-2). Regulation by phosphatidylinositol 4, 5-bisphosphate.
The Journal of biological chemistry 1998;273(34):21893-900.
1998: Irma Järvelä; Markku Sainio; T Rantamäki; V M Olkkonen; Olli Carpén; Leena Peltonen; Anu Jalanko
Biosynthesis and intracellular targeting of the CLN3 protein defective in Batten disease.
Human molecular genetics 1998;7(1):85-90.
1997: Antti Vaheri; Olli Carpén; Leena Heiska; TS Helander; Juha Jääskeläinen; P Majander-Nordenswan; Markku Sainio; Tuomo Timonen; O Turunen
The ezrin protein family: membrane-cytoskeleton interactions and disease associations.
Current opinion in cell biology 1997;9(5):659-66.
1997: Petteri Kauhanen; Vappu Sirén; Olli Carpén; Antti Vaheri; Mauri Lepäntalo; Riitta Lassila
Plasminogen activator inhibitor-1 in neointima of vein grafts: its role in reduced fibrinolytic potential and graft failure.
Circulation 1997;96(6):1783-9.
1997: Markku Sainio; Fang Zhao; Leena Heiska; O Turunen; Michael A Den Bakker; Ellen C Zwarthoff; M Lutchman; G A Rouleau; Juha Jääskeläinen; Antti Vaheri; Olli Carpén
Neurofibromatosis 2 tumor suppressor protein colocalizes with ezrin and CD44 and associates with actin-containing cytoskeleton.
Journal of cell science 1997;110 ( Pt 18)():2249-60.
1996: Leena Heiska; C Kantor; T Parr; D R Critchley; P Vilja; Carl G Gahmberg; Olli Carpén
Binding of the cytoplasmic domain of intercellular adhesion molecule-2 (ICAM-2) to alpha-actinin.
The Journal of biological chemistry 1996;271(42):26214-9.
1996: Perttu J Lindsberg; J Ohman; T Lehto; Marja-Liisa Karjalainen-Lindsberg; Anders Paetau; T Wuorimaa; Olli Carpén; Markku Kaste; Seppo Meri
Complement activation in the central nervous system following blood-brain barrier damage in man.
Annals of neurology 1996;40(4):587-96.
1996: Perttu J Lindsberg; Olli Carpén; Anders Paetau; Marja-Liisa Karjalainen-Lindsberg; Markku Kaste
Endothelial ICAM-1 expression associated with inflammatory cell response in human ischemic stroke.
Circulation 1996;94(5):939-45.
1996: T S Helander; Olli Carpén; O Turunen; P E Kovanen; Antti Vaheri; Tuomo Timonen
ICAM-2 redistributed by ezrin as a target for killer cells.
Nature 1996;382(6588):265-8.
1996: Olli Carpén; N Simberg; H Sasano; Eero Saksela
Virilizing ovarian leiomyoma: androgen production by lining stromal cells.
Acta obstetricia et gynecologica Scandinavica 1996;75(1):72-6.
1995: K Somersalo; Olli Carpén; Eero Saksela; Carl G Gahmberg; P Nortamo; Tuomo Timonen
Activation of natural killer cell migration by leukocyte integrin-binding peptide from intracellular adhesion molecule-2 (ICAM-2).
The Journal of biological chemistry 1995;270(15):8629-36.
1994: K Somersalo; Olli Carpén; Eero Saksela
Stimulated natural killer cells secrete factors with chemotactic activity, including NAP-1/IL-8, which supports VLA-4- and VLA-5-mediated migration of T lymphocytes.
European journal of immunology 1994;24(12):2957-65.
1994: S Tiisala; Marja-Leena Majuri; Olli Carpén; Risto Renkonen
Genistein enhances the ICAM-mediated adhesion by inducing the expression of ICAM-1 and its counter-receptors.
Biochemical and biophysical research communications 1994;203(1):443-9.
1994: S Tiisala; Marja-Leena Majuri; Olli Carpén; Risto Renkonen
Enhanced ICAM-1-dependent adhesion of myelomonocytic cells expressing increased levels of beta 2-integrins and CD43.
Scandinavian journal of immunology 1994;39(3):249-56.
1993: A Mäenpää; Juha Jääskeläinen; Olli Carpén; Manuel Patarroyo; Tuomo Timonen
Expression of integrins and other adhesion molecules on NK cells; impact of IL-2 on short- and long-term cultures.
International journal of cancer. Journal international du cancer 1993;53(5):850-5.
1990: M Jäättelä; Olli Carpén; Ulf-Hakan Stenman; Eero Saksela
Regulation of ACTH-induced steroidogenesis in human fetal adrenals by rTNF-alpha.
Molecular and cellular endocrinology 1990;68(2-3):R31-6.
1989: A K Ståhls; Olli Carpén
Generation of inositol phosphates during triggering of cytotoxicity in human natural killer and lymphokine-activated killer cells.
Scandinavian journal of immunology 1989;29(2):211-6.
1988: M K Heiskala; Ulf-Hakan Stenman; Erkki Koivunen; Olli Carpén; Eero Saksela; Tuomo Timonen
Characteristics of soluble tumour-derived proteins that inhibit natural killer activity.
Scandinavian journal of immunology 1988;28(1):19-27.
1988: Olli Carpén; Eero Saksela
Directed exocytosis in the NK-cell-mediated cytotoxicity. A review.
Natural immunity and cell growth regulation 1988;7(1):1-12.
1987: M K Heiskala; Olli Carpén; Eero Saksela; Tuomo Timonen
Mechanism of cell contact-mediated inhibition of natural killer activity.
Journal of immunology (Baltimore, Md. : 1950) 1987;139(5):1414-8.